Piper Sandler Reiterates Overweight Rating on BioCryst Pharma (BCRX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. NAVN
9. DFTX
10. IBM

Go back to Piper Sandler Reiterates Overweight Rating on BioCryst Pharma (BCRX)
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.14 --0 (-0%)
Previous Close $9.14    52 Week High $10.98 
Open $9.14    52 Week Low $1.63 
Day High $9.14    P/E N/A 
Day Low $9.14    EPS $-0.68 
Volume 10,775